GlassScriptPhysician profile
Kiera Irvin Rahaim
NPI 1710975099
$769.68
in general payments reported to CMS, 2019-2025
20 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $13.85 · 2021: $83.72 · 2022: $129 · 2023: $191 · 2024: $79.01 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.74 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $147.45 | 2019-2023 | |
| Pfizer INC. | $97.80 | 2021-2025 | |
| Astellas Pharma US INC | $90.79 | 2023 | Veozah |
| Coopersurgical, INC. | $60.22 | 2019-2025 | Ally II Ups, Paragard T 380a |
| Organon LLC | $37.80 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.96 | 2019-2024 | |
| Amgen INC. | $33.87 | 2022-2025 | Evenity |
| Millicent US INC | $33.83 | 2019-2025 | Intrarosa |
| Boston Scientific Corporation | $32.87 | 2019 | |
| Mayne Pharma Commercial LLC | $28.98 | 2025 | |
| Monaghan Medical Corporation | $26.57 | 2023 | Aerobika |
| Reapplix INC. | $22.55 | 2025 | 3c Patch Kit - Box |
| Scynexis, INC. | $18.40 | 2022 | |
| Meditrina | $18.32 | 2024 | |
| Merck Sharp & Dohme LLC | $17.74 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $14.25 | 2023 | Renasys Touch, Pico |
| Therapeuticsmd, INC. | $13.92 | 2019 | |
| Agile Therapeutics, INC. | $13.50 | 2021 | |
| Axonics, INC. | $12.77 | 2022 | |
| Lupin INC. | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiera Irvin Rahaim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.